BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER · 20 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 3,124 | $121.67 | $380,097.08 | filing |
| 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 1,048 | $122.43 | $128,306.64 | filing |
| 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 528 | $123.84 | $65,387.52 | filing |
| 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 300 | $124.94 | $37,482.00 | filing |
| 2026-06-09 | MIRM | Mirum Pharmaceuticals, Inc. | Option exercise | 2,393 | $26.49 | $63,390.57 | filing |
| 2026-06-09 | CERS | CERUS CORP | Sale | 20,454 | $2.60 | $53,180.40 | filing |
| 2026-06-08 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 2,258 | $92.84 | $209,632.72 | filing |
| 2026-06-08 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 1,567 | $95.12 | $149,053.04 | filing |
| 2026-06-08 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 1,175 | $93.95 | $110,391.25 | filing |
| 2026-06-02 | CERS | CERUS CORP | Award | 60,000 | $0.00 | $0.00 | filing |
| 2026-03-16 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 7,287 | $91.98 | $670,242.96 | filing |
| 2026-03-15 | MIRM | Mirum Pharmaceuticals, Inc. | Option exercise | 13,334 | — | — | filing |
| 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 1,053 | $96.19 | $101,290.18 | filing |
| 2026-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | Option exercise | 2,667 | — | — | filing |
| 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 1,421 | $93.33 | $132,615.11 | filing |
| 2026-01-21 | MIRM | Mirum Pharmaceuticals, Inc. | Option exercise | 3,334 | — | — | filing |
| 2025-09-12 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 9,578 | $76.01 | $728,023.78 | filing |
| 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | Option exercise | 18,333 | — | — | filing |
| 2025-08-12 | MIRM | Mirum Pharmaceuticals, Inc. | Option exercise | 2,954 | $26.49 | $78,251.46 | filing |
| 2025-08-11 | MIRM | Mirum Pharmaceuticals, Inc. | Sale | 8,000 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.